
MadeMed Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.4/10
Best for: compounded GLP-1 in both injection and oral forms
MadeMed scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
Price checked on MadeMed’s site,
What the monthly price covers
Medication
Not stated
Provider visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
PartnerMadeMed is a partner: we may earn a commission if you sign up through our links. It doesn't affect the score. How we make money
MadeMed (MadeMed LLC, based in Houston, Texas) is a LegitScript-certified telehealth platform selling compounded semaglutide and tirzepatide injections and a tirzepatide sublingual tablet, alongside hair, hormone, sexual-health and longevity treatments. Each product page lists one price at every dose: semaglutide is $179 and tirzepatide $249 billed every 30 days, with lower monthly rates on 90- and 360-day plans and a $20 consultation fee. It names its partner pharmacies and publishes a customer support line.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
MadeMed at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $179/mo
- FDA status
- No FDA warning letter on record
How we scored MadeMed
Each dimension is scored algorithmically from MadeMed’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.5/10At $179/mo, MadeMed runs in line with the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
8.4/10MadeMed offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.4/10Online intake and platform experience; 6 platform features disclosed.
Trust & Safety15%
7.2/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.3/10MadeMed's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
6.1/10MadeMed provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this MadeMed review
Last checked November 2026- Confirmed current pricing across 3 dose/plan tiers
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $179–$249/mo across 3 dose/plan tiers (checked November 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with MadeMed
We walked MadeMed’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Browse treatments with prices shown up front (Injectable Semaglutide from $143/mo, Injectable Tirzepatide from $199/mo, Tirzepatide Sublingual Tablet from $199/mo on the 360-day plan)
- 2Complete a quick online visit about your health history (no video call required)
- 3A U.S.-licensed, board-certified physician reviews your information to decide if a prescription is appropriate
- 4If approved, your treatment ships discreetly and free from a licensed U.S. compounding pharmacy
- 5Message the medical team any time through the secure messaging portal
- LegitScript-certified telehealth; consultations reviewed by board-certified U.S. physicians licensed in your state
- Prices are shown up front on each product page: semaglutide $179 and tirzepatide $249 billed every 30 days, with lower rates on 90- and 360-day plans
- Does not accept insurance; product pages say HSA/FSA may apply
- Fully asynchronous: no live video visit and no lab work required to get started
- Medications compounded and shipped from licensed, accredited U.S. pharmacies
GLP-1 medications MadeMed offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides MadeMed offers
Beyond GLP-1s, MadeMed also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
$179 billed every 30 days, $161 a month on the 90-day plan (billed $483), or $143 a month on the 360-day plan (billed $1,718). A $20 consultation fee ($30 for a video visit) applies.
$249 billed every 30 days, $224 a month on the 90-day plan (billed $672), or $199 a month on the 360-day plan (billed $2,390). A $20 consultation fee ($30 for a video visit) applies.
$249 billed every 30 days, $224 a month on the 90-day plan (billed $672), or $199 a month on the 360-day plan (billed $2,390). A $20 consultation fee applies.
Ready to get started?
Plans and promotions change often, so check MadeMed's current pricing and active discounts before you decide.
What we like
- Three GLP-1 options, including a compounded tirzepatide sublingual tablet for people who would rather avoid needles
- LegitScript certification badge on the homepage
- Customer phone support published (1-800-582-1428), which is uncommon among chat-only competitors
Watch-outs
- A $20 consultation fee ($30 for a video visit) is charged even if no prescription is issued
- Only the oral tirzepatide page lists states (40, excluding AL, AK, AR, HI, MA, MO, NM, NY, SC and VA); injectable coverage isn't stated
- No individual medical director named; the Terms name only the medical group, MDI Medical Group PC
- Terms require binding individual arbitration and waive class actions
MadeMed in one line: flat GLP-1 pricing at every dose, with a tablet option for tirzepatide
MadeMed is a direct-to-consumer telehealth platform, run by MadeMed LLC of Houston, Texas, that sells compounded semaglutide and tirzepatide injections plus a tirzepatide tablet that dissolves under the tongue. That tablet matters if you dread needles, because most GLP-1 services hand you a syringe and call it a day. Each product page prints one price for every dose, so you can see what you'll pay before you start a consult. The main add-on is a small consultation fee on each order.
How the pricing works
MadeMed prices by billing cycle, not by dose. Compounded semaglutide is $179 billed every 30 days, with lower monthly rates on a 90-day plan and $143 a month on a 360-day plan. Tirzepatide, injection or tablet, is $249 every 30 days and drops to $199 a month on the 360-day plan. The product pages say the price stays the same from the starting dose to the top one, which removes the usual jump as you titrate up.
- Budget for the consult: each order carries a $20 consultation fee ($30 if a video visit is needed), and it is kept even if you are not prescribed.
- Know what a long plan commits you to: the 360-day rate is the cheapest, but it is billed as one charge, and MadeMed's terms give no prorated refunds after you cancel.
- Pausing and canceling: its FAQ says you can pause or cancel from your account, and cancellation takes effect at the end of the current billing period.
The medications: a tablet option for tirzepatide
The weight-loss menu has three GLP-1 products: injectable semaglutide, injectable tirzepatide, and a 3 mg tirzepatide sublingual tablet. Tirzepatide is the dual-action drug behind the strongest weight-loss numbers in trials. A needle-free version of it is still uncommon. MadeMed does not sell an oral semaglutide, so the tablet is the only route for someone who wants to avoid injections.
The tablet carries a caveat: compounded tablets taken under the tongue have not been tested in large trials, and peptides absorbed that way are generally less efficient than injections. Ask the prescribing doctor how the tablet compares with the shot before you assume they deliver the same result.
What MadeMed discloses, and what it doesn't
MadeMed displays a LegitScript certification badge and links to LegitScript's own lookup, so you can check the listing yourself. It names the 503A compounding pharmacies it partners with (Absolute RX, Strive Pharmacy, ERX Hub, and Southend Pharmacy) and publishes a support phone line (1-800-582-1428), which suggests a human is reachable if something goes wrong with your order. Its terms name the medical group, MDI Medical Group PC, and set Texas law with binding individual arbitration for disputes.
- No named medical director: the site says board-certified physicians licensed in your state review each consult, and the terms name the medical group, but no individual clinical leader is named.
- A partial state list: the tirzepatide tablet page says it's offered in 40 states and not in Alabama, Alaska, Arkansas, Hawaii, Massachusetts, Missouri, New Mexico, New York, South Carolina or Virginia. The injection pages don't list states, so confirm yours before you start.
- No pharmacy match: the site names four partner pharmacies but doesn't say which one will fill your order.
Who should consider MadeMed, and who shouldn't
Consider it if you want a flat price that won't rise with your dose, or a tirzepatide tablet instead of a weekly shot. The published prices, named pharmacies, and live phone line put it ahead of the more anonymous compounding sellers. People who want to see how much of their loss is fat versus muscle can look at HumeCare+, which includes a body-composition device with its flat-priced compounded plans. Worth knowing: it doesn't show a price until you finish its intake quiz.
Skip it if you want oral semaglutide, which it doesn't sell, or if a named medical director is non-negotiable for you. If you live in one of the 10 states where the tablet isn't offered, it's injections only, and for those the site doesn't list states, so ask support first. If you're in perimenopause or menopause and want insurance in the picture, Midi Health serves all 50 states and can prescribe a GLP-1 within its menopause care, at the clinician's discretion. You can see how we weigh transparency and oversight in our scoring methodology.
Trust and safety: good signals, a few gaps
There are no FDA warning letters on file for MadeMed, and the LegitScript certification, named 503A pharmacies, and published phone support are legitimate positives. The gaps that remain are the unnamed individual medical director and the missing state list for the injections. None of that means MadeMed is unsafe. Ask about both before you order.
Bottom line
MadeMed gives you a clear price before you start: $179 every 30 days for semaglutide and $249 for tirzepatide, the same at every dose, plus a $20 consult fee. Its tirzepatide tablet gives needle-averse patients a choice of format. The partner pharmacies are named. Confirm the format you want is offered in your state and ask which pharmacy will fill your prescription, and it can be a fair option.
The Bottom Line
MadeMed scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with MadeMed?
From $179/mo. See current pricing and start your free consultation.
MadeMed might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to MadeMed
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Head-to-head
Compare MadeMed vs…
MadeMed scores7.4/10
Side-by-side pricing, medications and scores. Pick a matchup.
MadeMed vs Amazon One Medical
Amazon One Medical scores 8.5/10

MadeMed vs Vytora Health
Vytora Health scores 8.4/10

MadeMed vs CoreAge Rx
CoreAge Rx scores 8.3/10

MadeMed vs Collective
Collective scores 8.3/10

MadeMed vs Found
Found scores 8.3/10
MadeMed vs EverSlim
EverSlim scores 8.3/10
All 45 MadeMed comparisons
- MadeMed vs AgelessRx
- MadeMed vs altRX
- MadeMed vs Belle Health
- MadeMed vs bmiMD
- MadeMed vs Bodybuilding Health+
- MadeMed vs Brightmeds
- MadeMed vs Direct Meds
- MadeMed vs DudeMeds
- MadeMed vs Eden
- MadeMed vs Embody
- MadeMed vs Enhance MD
- MadeMed vs Gala
- MadeMed vs GobyMeds
- MadeMed vs HealthRX
- MadeMed vs HumeCare+
- MadeMed vs Ivim Health
- MadeMed vs Live Vital
- MadeMed vs Lttl
- MadeMed vs Luvo Health
- MadeMed vs MangoRx
- MadeMed vs Maximus
- MadeMed vs MEDGm
- MadeMed vs MEDVi
- MadeMed vs Midi Health
- MadeMed vs NewSelf
- MadeMed vs Oak
- MadeMed vs PlexusDx
- MadeMed vs Ro
- MadeMed vs RxSpan MD
- MadeMed vs Sesame Care
- MadeMed vs ShedRx
- MadeMed vs SkinnyRx
- MadeMed vs SnagRx
- MadeMed vs Sprout Health
- MadeMed vs Strut Health
- MadeMed vs TMates
- MadeMed vs TrimRx
- MadeMed vs Wellorithm
- MadeMed vs YourEra
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this MadeMed review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See MadeMed's current pricing
Plans from $179/mo. Start your free consultation to check eligibility and today's price.